Domino dendrimers

被引:21
作者
Amir, RJ [1 ]
Shabat, D [1 ]
机构
[1] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel
来源
POLYMER THERAPEUTICS I: POLYMERS AS DRUGS, CONJUGATES AND GENE DELIVERY SYSTEMS | 2006年 / 192卷
关键词
biosensor; cancer; dendrimer; prodrug; self-immolative;
D O I
10.1007/12_021
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Domino dendrimers have recently been developed and introduced as a potential platform for a single triggered multi-prodrug. Surprisingly, three independent groups reported similar concepts almost simultaneously. These unique structural dendrimers can release all of their tail units, through a domino-like chain fragmentation, which is initiated by a single cleavage at the dendrimer's core. This chapter reviews the recent efforts to design domino-like dendrimers with emphasis on the application of drug delivery. Incorporation of drug molecules as the tail units and an enzyme substrate as the trigger, can generate a multi-prodrug unit that is activated with a single enzymatic cleavage. Dendritic prodrugs, activated through a single catalytic reaction by a specific enzyme, could present significant advantages in the inhibition of tumor growth, especially if the targeted or secreted enzyme exists at relatively low levels in the malignant tissue. Domino dendrimers may also be applied as a general platform for biosensor molecules, used to detect enzymatic activity.
引用
收藏
页码:59 / 94
页数:36
相关论文
共 43 条
[1]   Self-immolative dendrimer biodegradability by multi-enzymatic triggering [J].
Amir, RJ ;
Shabat, D .
CHEMICAL COMMUNICATIONS, 2004, (14) :1614-1615
[2]   Self-immolative dendrimers [J].
Amir, RJ ;
Pessah, N ;
Shamis, M ;
Shabat, D .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (37) :4494-4499
[3]   Dendrimers: a new class of nanoscopic containers and delivery devices [J].
Aulenta, F ;
Hayes, W ;
Rannard, S .
EUROPEAN POLYMER JOURNAL, 2003, 39 (09) :1741-1771
[4]   A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J].
BAGSHAWE, KD ;
SPRINGER, CJ ;
SEARLE, F ;
ANTONIW, P ;
SHARMA, SK ;
MELTON, RG ;
SHERWOOD, RF .
BRITISH JOURNAL OF CANCER, 1988, 58 (06) :700-703
[5]   Optimizing saccharide-directed molecular delivery to biological receptors:: Design, synthesis, and biological evaluation of glycodendrimer -: Cyclodextrin conjugates [J].
Benito, JM ;
Gömez-García, M ;
Mellet, CO ;
Baussanne, I ;
Defaye, J ;
Fernández, JMG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (33) :10355-10363
[6]   Dendrimers in drug research [J].
Boas, U ;
Heegaard, PMH .
CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) :43-63
[7]   About dendrimers: Structure, physical properties, and applications [J].
Bosman, AW ;
Janssen, HM ;
Meijer, EW .
CHEMICAL REVIEWS, 1999, 99 (07) :1665-1688
[8]   The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability [J].
D'Emanuele, A ;
Jevprasesphant, R ;
Penny, J ;
Attwood, D .
JOURNAL OF CONTROLLED RELEASE, 2004, 95 (03) :447-453
[9]   Cascade-release dendrimers liberate all end groups upon a single triggering event in the dendritic core [J].
de Groot, FMH ;
Albrecht, C ;
Koekkoek, R ;
Beusker, PH ;
Scheeren, HW .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (37) :4490-4494
[10]  
de Groot FMH, 2001, CURR MED CHEM, V8, P1093